Most recently, a detailed bioinformatic analysis revealed the oncogenic role of TPD52L2 in lung adenocarcinoma and demonstrated that its high expression is associated with immune infiltration and tumor immunosuppressive status, further supporting our results [29]. The gene discussed is TPD52L2; the disease is lung adenocarcinoma.